|
Gabapentin Clinical Trials
3 actively recruiting trials across 2 locations
▼ -1 trial since August 2026
Also known as: Gralise, Neurontin
Pipeline
Phase 3: 1Phase 1/2: 2
Top Sponsors
- University of Zurich1
- Natalie Lockney1
- Alliance for Clinical Trials in Oncology1
Indications
- Cancer3
- Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v81
- Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v81
- Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v81
- Locally Advanced Head and Neck Carcinoma1
Other1 trial
Phase 1/2
Gilbert, Arizona1 trial
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Arizona Center for Cancer Care - Gilbert
Phase 3
Nashville, Tennessee1 trial
Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.